111 related articles for article (PubMed ID: 37715422)
1. The expression and clinical value of LRP11, FUBP1 and TET1 in cervical cancer.
Zhao X; Li S; Wen J; Li Y
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):80-84. PubMed ID: 37715422
[TBL] [Abstract][Full Text] [Related]
2. An integrative pan-cancer analysis illustrating the key role of LRP11 in cervical cancer.
Gu F; Xu F; Pan Z; Shi L; Yu J; Song F; Huang S; Sun M
Medicine (Baltimore); 2023 Mar; 102(11):e33201. PubMed ID: 36930084
[TBL] [Abstract][Full Text] [Related]
3. High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications.
Dutta P; Basu M; Roy A; Mandal RK; Panda CK
J Mol Histol; 2023 Feb; 54(1):89-102. PubMed ID: 36692670
[TBL] [Abstract][Full Text] [Related]
4. TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
Ren J; Chen X; Li J; Zan Y; Wang S; Tan Y; Ding Y
Epigenetics; 2024 Dec; 19(1):2323751. PubMed ID: 38431880
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosis.
Ma C; Huang Z; Wu Z; Di C; Lin X; Huang M; Hong H; Yin H
Life Sci; 2021 Mar; 269():119098. PubMed ID: 33476628
[TBL] [Abstract][Full Text] [Related]
6. TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer.
Yang B; Chen J; Teng Y
J Immunol Res; 2021; 2021():9994004. PubMed ID: 33987449
[TBL] [Abstract][Full Text] [Related]
7. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
8. Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition.
Gao J; Liu R; Feng D; Huang W; Huo M; Zhang J; Leng S; Yang Y; Yang T; Yin X; Teng X; Yu H; Yuan B; Wang Y
Cell Death Differ; 2021 Sep; 28(9):2818-2836. PubMed ID: 33953349
[TBL] [Abstract][Full Text] [Related]
9. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
10. TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions.
Su PH; Hsu YW; Huang RL; Chen LY; Chao TK; Liao CC; Chen CW; Wu TI; Mao SP; Balch C; Lai HC
Cancer Lett; 2019 May; 450():53-62. PubMed ID: 30771438
[TBL] [Abstract][Full Text] [Related]
11. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis.
Sang Y; Cheng C; Tang XF; Zhang MF; Lv XB
Asian Pac J Cancer Prev; 2015; 16(3):1197-200. PubMed ID: 25735355
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
14. The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer.
Wang Y; Han S; You X; Shi X; Liu L; Sun Y; Ma Y; Qian Q; Liu H; Cui B; Zhang Y
Cancer Manag Res; 2019; 11():8081-8093. PubMed ID: 31507330
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma.
Chen Y; Liu J; Geng N; Feng C
Int J Biol Markers; 2020 Jun; 35(2):56-65. PubMed ID: 32339054
[TBL] [Abstract][Full Text] [Related]
16. Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation.
Lai JI; Lai YC; Chen YC; Wang NK; Pan JN; Wang WS; Chang SC
Cancer Gene Ther; 2017 Sep; 24(9):373-380. PubMed ID: 28776568
[TBL] [Abstract][Full Text] [Related]
17. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
[TBL] [Abstract][Full Text] [Related]
18. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
[TBL] [Abstract][Full Text] [Related]
19. Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
Lin LL; Wang W; Hu Z; Wang LW; Chang J; Qian H
Med Oncol; 2015 Mar; 32(3):39. PubMed ID: 25616722
[TBL] [Abstract][Full Text] [Related]
20. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.
Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
Bioengineered; 2022 May; 13(5):12115-12126. PubMed ID: 35546072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
